4//SEC Filing
Novartis Bioventures Ltd 4
Accession 0001104659-19-032920
CIK 0001761612other
Filed
May 29, 8:00 PM ET
Accepted
May 30, 9:27 PM ET
Size
18.2 KB
Accession
0001104659-19-032920
Insider Transaction Report
Form 4
Novartis Bioventures Ltd
10% Owner
Transactions
- Conversion
Ordinary Shares
2019-05-28+893,195→ 893,195 total - Conversion
Ordinary Shares
2019-05-28+636,366→ 1,601,011 total - Purchase
Ordinary Shares
2019-05-28$14.00/sh+168,630$2,360,820→ 1,769,641 total - Conversion
Series B1 Preferred Shares
2019-05-28−636,366→ 0 total→ Ordinary Shares (636,366 underlying) - Exercise of In-Money
Ordinary Shares
2019-05-28+71,450→ 964,645 total - Conversion
Series A Preferred Shares
2019-05-28−893,195→ 0 total→ Ordinary Shares (893,195 underlying) - Exercise of In-Money
Series A Preferred Shares Warrants
2019-05-28−71,450→ 0 total→ Ordinary Shares (71,450 underlying)
NOVARTIS AG
10% Owner
Transactions
- Conversion
Series B1 Preferred Shares
2019-05-28−636,366→ 0 total→ Ordinary Shares (636,366 underlying) - Conversion
Ordinary Shares
2019-05-28+893,195→ 893,195 total - Exercise of In-Money
Series A Preferred Shares Warrants
2019-05-28−71,450→ 0 total→ Ordinary Shares (71,450 underlying) - Conversion
Ordinary Shares
2019-05-28+636,366→ 1,601,011 total - Purchase
Ordinary Shares
2019-05-28$14.00/sh+168,630$2,360,820→ 1,769,641 total - Conversion
Series A Preferred Shares
2019-05-28−893,195→ 0 total→ Ordinary Shares (893,195 underlying) - Exercise of In-Money
Ordinary Shares
2019-05-28+71,450→ 964,645 total
Footnotes (2)
- [F1]Each Series A and B1 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date.
- [F2]Upon conversion of all of the Series B1 Preferred Shares into Ordinary Shares in connection with the Issuer's initial public offering, the Warrants became exercisable for Ordinary Shares. The Warrants had an exercise price of a nominal value per share and were exercised immediately prior to completion of the Issuer's initial public offering.
Documents
Issuer
BICYCLE THERAPEUTICS plc
CIK 0001761612
Entity typeother
IncorporatedBermuda
Related Parties
1- filerCIK 0001297709
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 9:27 PM ET
- Size
- 18.2 KB